Robert Austrian

Q: What Schools Are Affiliated With Robert Austrian

Robert Austrian is affiliated with the following schools: University at Buffalo, Johns Hopkins University, University of California, San Francisco, Columbia University, New York University, University of Pennsylvania

Robert Austrian's AcademicInfluence.com Rankings

Robert Austrian

Philosophy

#6103

World Rank

#9077

Historical Rank

#1492

USA Rank

Logic

#3487

World Rank

#4655

Historical Rank

#708

USA Rank

philosophy Degrees

Download Badge

Philosophy

Robert Austrian's Degrees

Doctorate Medicine Columbia University

Why Is Robert Austrian Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Robert Austrian was an Americann infectious diseases physician and, along with Maxwell Finland, one of the two most important researchers into the biology of Streptococcus pneumoniae in the 20th century.

(See a Problem?)

Robert Austrian's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children (2000) (2192)
The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. (1991) (1036)
PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA. (1964) (915)
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. (2000) (733)
Emergence of multiply resistant pneumococci. (1978) (644)
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. (1983) (548)
Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization (1994) (439)
Prevention of pneumococcal pneumonia by vaccination. (1976) (397)
Pathogenesis of pneumococcal infection. (1995) (341)
Postlicensure Surveillance for Pneumococcal Invasive Disease After Use of Heptavalent Pneumococcal Conjugate Vaccine in Northern California Kaiser Permanente (2004) (336)
Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. (1981) (295)
The quellung reaction, a neglected microbiologic technique. (1976) (287)
Clinical and physiologic features of some types of pulmonary diseases with impairment of alveolar-capillary diffusion; the syndrome of "alveolar-capillary block". (1951) (242)
Some aspects of the pneumococcal carrier state. (1986) (229)
Coordination of the synthesis of the enzymes in the pyrimidine pathway of E. coli. (1962) (206)
A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques. (1980) (185)
Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. (1975) (167)
Pneumococcus: the first one hundred years. (1981) (155)
Why have group A streptococci remained susceptible to penicillin? Report on a symposium. (1998) (137)
The Antibody Responses to Pneumococcal Capsular Polysaccharides in Aged Individuals 1 (1980) (109)
Pneumococcal endocarditis, meningitis, and rupture of the aortic valve. (1957) (101)
The bacteriology of pneumococcal otitis media. (1977) (97)
The pneumococcus at the millennium: not down, not out. (1999) (88)
THE GRAM STAIN AND THE ETIOLOGY OF LOBAR PNEUMONIA, AN HISTORICAL NOTE (1960) (84)
Surveillance for Invasive Pneumococcal Disease During 2000–2005 in a Population of Children Who Received 7-Valent Pneumococcal Conjugate Vaccine (2007) (84)
BACTEREMIA CAUSED BY PSEUDOMONAS SP. FOLLOWING THE USE OF MATERIALS STORED IN SOLUTIONS OF A CATIONIC SURFACE‐ACTIVE AGENT (1958) (82)
Maxwell Finland Lecture. Random gleanings from a life with the pneumococcus. (1975) (80)
Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines. (1977) (80)
Efficacy of Heptavalent Conjugate Pneumococcal Vaccine (Wyeth Lederle) in 7,000 Infants and Children: Results of the Northern California Kaiser Permanente Efficacy Trial (1999) (78)
Immune Response to Acute Otitis Media in Children I. Serotypes Isolated and Serum and Middle Ear Fluid Antibody in Pneumococcal Otitis Media (1974) (73)
Pneumococcal polysaccharide vaccines. (1989) (72)
Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis. (2003) (69)
From the center for disease control. Epidemiology of pneumococcal serotypes in the United States, 1978--1979. (1980) (68)
Confronting Drug-resistant Pneumococci (1994) (66)
SIMULTANEOUS PRODUCTION OF TWO CAPSULAR POLYSACCHARIDES BY PNEUMOCOCCUS (1959) (65)
Pneumococcal infection and pneumococcal vaccine. (1977) (65)
Serotypes responsible for invasive Streptococcus pneumoniae infections among children in Connecticut. (1994) (65)
Novel penicillin-resistant clones of Streptococcus pneumoniae in the Czech Republic and in Slovakia. (1995) (61)
Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults. (2006) (58)
SOME BIOLOGICAL PROPERTIES OF PNEUMOCOCCUS TYPE 37 AND THE CHEMISTRY OF ITS CAPSULAR POLYSACCHARIDE (1970) (55)
Pneumococcal pneumonia. Diagnostic, epidemiologic, therapeutic and prophylactic considerations. (1986) (55)
Fatal pneumococcal bacteremia in a vaccinated splenectomized child. (1979) (48)
A reassessment of pneumococcal vaccine. (1984) (47)
A TYPE-SPECIFIC PROTEIN FROM PNEUMOCOCCUS (1948) (46)
SIMULTANEOUS PRODUCTION OF TWO CAPSULAR POLYSACCHARIDES BY PNEUMOCOCCUS (1959) (46)
Pneumococcal vaccine: development and prospects. (1979) (44)
Immune Response to Acute Otitis Media in Children I. Serotypes Isolated and Serum and Middle Ear Fluid Antibody in Pneumococcal Otitis Media (1974) (41)
Type variation of strains of Streptococcus pneumoniae in capsular serogroup 15. (1983) (40)
Pneumococcal infection. (1974) (37)
Antibiotic‐resistant pneumococcal disease in children at Baragwanath Hospital, Johannesburg (1986) (37)
The enduring pneumococcus: unfinished business and opportunities for the future. (1997) (37)
The presence of an uronic acid epimerase in a strain of pneumococcus type I. (1958) (35)
Qualitative Differences in the Behavior of Pneumococcal Deoxyribonucleic Acids Transforming to the Same Capsular Type (1967) (33)
Morphologic variation in pneumococcus. I. An analysis of the bases for morphologic variation in pneumococcus and description of a hitherto undefined morphologic variant. (1953) (31)
CAPSULATION OF PNEUMOCOCCUS WITH SOLUBLE C-LIKE (Cs) POLYSACCHARIDE (1968) (31)
Epidemiology of pneumococcal capsular types causing pediatric infections (1989) (30)
Prospects for the prevention of bacterial meningitis with polysaccharide vaccines. (1978) (29)
Penicillin-resistant and multidrug-resistant Streptococcus pneumoniae in a pediatric hospital in Zagreb, Croatia. (1995) (29)
The synthesis of type III pneumococcal capsular polysaccharide from uridine nucleotides by a cell-free extract of Diplococcus pneumoniae type III. (1960) (29)
Pyogenic Liver Abscess Secondary to Asymptomatic Sigmoid Diverticulitis (1976) (28)
Distribution of serotypes of Streptococcus pneumoniae isolated from invasive infections over a 16-year period in the greater São Paulo area, Brazil (1995) (28)
CAPSULATION OF PNEUMOCOCCUS WITH SOLUBLE CELL WALL-LIKE POLYSACCHARIDE (1971) (27)
Importance of Carbon Dioxide in the Isolation of Pneumococci (1966) (26)
The formation of uridine pyrophosphoglucuronic acid from uridine pyrophosphoglucose by extracts of a noncapsulated strain of pneumococcus. (1958) (26)
Bacterial Transformation Reactions (1952) (25)
Treasured objects in school-aged children. (1981) (25)
Pneumococcal otitis media and pneumococcal vaccines, a historical perspective. (2000) (23)
The assessment of pneumococcal vaccine. (1980) (23)
The syndrome of pneumococcal endocarditis, meningitis and rupture of the aortic valve. (1956) (23)
Cross-Immunogenicity of Pneumococcal Group 9 Capsular Polysaccharides in Adult Volunteers (1982) (22)
A study of some enzymes in extracts of a non-capsulated strain of pneumococcus concerned with uridine pyrophosphoglycosyl metabolism. (1959) (21)
Observations on tsutsugamushi disease (scrub typhus) in Assam and Burma: the recovery of strains of Rickettsia orientalis. (1947) (21)
Reviews of Infectious Diseases (2016) (21)
Pneumonia in the Later Years * (1981) (20)
Serologic and genetic relationships between pneumococci and other respiratory streptococci. (1966) (19)
THE EFFICACY OF PENICILLIN V (PHENOXYMETHYLPENICILLIN) IN THE TREATMENT OF MILD AND OF MODERATELY SEVERE PNEUMOCOCCAL PNEUMONIA (1956) (19)
Recurrent pneumococcal bacteremia in normal children. (1994) (18)
Current status of bacterial pneumonia with special reference to pneumococcal infection. (1968) (18)
ACQUISITION OF M PROTEIN BY PNEUMOCOCCI THROUGH TRANSFORMATION REACTIONS (1949) (17)
The bacterial flora of the respiratory tract. Some knowns and unknowns. (1968) (17)
Uridine pyrophosphoglucose dehydrogenase in capsulated and non-capsulated strains of pneumococcus type I. (1960) (17)
THE CHROMOSOMAL LOCATION OF THE STRUCTURAL GENE FOR OROTIDYLIC ACID PYROPHOSPHORYLASE IN ESCHERICHIA COLI. (1964) (17)
Streptococcus pneumoniae type 16A, a hitherto undescribed pneumococcal type (1985) (16)
9 – Pneumococcal Infections (1984) (16)
Pneumococcal infections in sickle cell anemia. (1972) (15)
The Jeremiah Metzger Lecture: Of gold and pneumococci: a history of pneumococcal vaccines in South Africa. (1978) (14)
Morphologic variation in pneumococcus. II. Control of pneumococcal morphology through transformation reactions. (1953) (13)
Immunization of elderly people with polyvalent pneumococcal vaccine (1989) (13)
Observations on the transformation of Pneumococcus in vivo. (1952) (11)
Mutation in Pneumococcus Type III Affecting Multiple Cistrons Concerned with the Synthesis of Capsular Polysaccharide (1968) (11)
Pneumococcus and the Brooklyn connection. (1999) (10)
Polysaccharide vaccines. (1985) (10)
Prevention of fatal bacterial infection in patients with anatomic or functional asplenia. (1982) (10)
THE PREVALENCE OF PNEUMOCOCCAL TYPES AND THE CONTINUING IMPORTANCE OF PNEUMOCOCCAL INFECTION (1959) (9)
Untreated pneumococcal bacteraemia of cryptic origin in the human adult with spontaneous recovery. (1986) (9)
WHO Recommendations on Pneumococcal Vaccination (1989) (9)
Oswald T. Avery: the Wizard of York Avenue. (1999) (8)
Cephaloridine and penicillin G in the treatment of pneumococcal pneumonia. A comparative study. (1967) (8)
The efficacy of modified oral penicillin therapy of pneumococcal lobar pneumonia. (1951) (8)
THE RELATIVE EFFICACY OF ERYTHROMYCIN (ILOTYCIN) AND OF PENICILLIN IN THE TREATMENT OF PNEUMOCOCCAL LOBAR PNEUMONIA (1953) (8)
Acquisition of new capsular type by pneumococcus, a multifactor transformation. (1958) (7)
The pneumococcus at Hopkins: early portents of future developments. (1979) (7)
The development of pneumococcal vaccine. (1981) (7)
Life with the Pneumococcus: Notes from the Bedside, Laboratory, and Library (1985) (7)
Lincomycin and penicillin G in the treatment of mild and moderately severe pneumococcal pneumonia. A comparative study. (1968) (6)
8. Of Gold and Pneumococci: A History of Pneumococcal Vaccines in South Africa (1985) (6)
THE ROLE OF TOXEMIA AND OF NEURAL INJURY IN THE OUTCOME OF PNEUMOCOCCAL MENINGITIS (1964) (6)
Filamentous Capsulated Streptococci from the Human Respiratory Tract I. Antigenic Attributes of Provisional Capsular Type 83 and Its Relationship to Streptococci of So-Called Group M (1973) (6)
[Serotypes of Streptococcus pneumoniae isolated from cerebrospinal fluid in 1977-1988 in São Paulo City, Brazil]. (1990) (6)
Modification of the fermentative activities of Pneumococcus through transformation reactions. (1953) (5)
Observations on the possible role of nucleic acid exchange reactions in pneumococcal capsular type transformation; a preliminary note. (1952) (5)
Filamentous Capsulated Streptococci from the Human Respiratory Tract II. Antigenic Structure of Provisional Capsular Types 89 and 83/89 (1973) (5)
Filamentous Capsulated Streptococci from the Human Respiratory Tract: Chemical and Immunochemical Characterization of a Glycoprotein Capsular Antigen of Provisional Binary Capsular Type 87 (1978) (5)
Filamentous Capsulated Streptococci from the Human Respiratory Tract III. Immunochemical Studies of the Cross-Reactivity Between the Cell Wall Antigens of a Filamentous Streptococcus and of Pneumococcus (1973) (5)
Correction: pneumococcal vaccine and pneumococcal pneumonia. (1988) (5)
Pneumococcal vaccines for the world. (1999) (4)
Diabetes Mellitus and the Pneumococcus (1980) (4)
Some contributions of pneumococcal genetics to the elucidation of biological phenomena. (1960) (4)
MORPHOLOGIC VARIATION IN PNEUMOCOCCUS (1953) (4)
Effect of pneumococcal polysaccharide vaccine on nonbacteremic pneumococcal pneumonia. (2007) (4)
Current status of therapy in the pneumonias. (1957) (4)
The current status of polyvalent pneumococcal vaccine. (1984) (4)
BACTERIAL TRANSFORMATION REACTIONS (1952) (3)
NEED FOR AGREEMENT ON A SINGLE PNEUMOCOCCAL VACCINE FORMULATION (1980) (3)
Labeling and Unlabeling: Perceptions of Diagnostic Terms Among Mothers and Professionals (1981) (3)
Pneumococcal pneumonia and pneumococcal vaccine. (1981) (3)
Streptococcus pneumoniae (pneumococcus) (2014) (3)
Microbiology and clinical medicine--a personal view. (1972) (2)
Tracking the Identity of Lister's Pneumococcal Groups T and V (Danish Types 45 and 46) (1982) (2)
6. The Current Status of Bacteremic Pneumococcal Pneumonia: Re-evaluation of an Underemphasized Clinical Problem (1985) (2)
Diabetes mellitus and the pneumococcus. Another point of view. (1980) (2)
The efficacy of aureomycin in the treatment of pneumococcal lobar pneumonia. (1951) (2)
Preventive Medicine in World War II (2015) (2)
Bacterial Polysaccharide Vaccines (2011) (2)
Of Man and Pneumococcus, An Historical Paradox (1971) (2)
A comparison of the efficacy of chloramphenicol and of penicillin in the treatment of pneumococcal lobar pneumonia (1952) (1)
Concerning Osler and Agnew. A note on historical discrepancies. (1984) (1)
MORPHOLOGIC VARIATION IN PNEUMOCOCCUS (1953) (1)
STUDIES ON THE ANTIBACTERIAL ACTION OF THE SULFONAMIDE DRUGS (1942) (1)
Transformation of Pneumococcal M Protein (1966) (1)
Further Observation on the Treatment of Yaws with Penicillin. (1945) (1)
THE ROLE OF TOXEMIA AND OF NEURAL INJURY IN THE OUTCOME OF PNEUMOCOCCAL MENINGITIS. (1964) (1)
A type specific protein from pneumococcus. (1948) (1)
Colin Munro MacLeod, 1909-1972. (1973) (1)
The role of the microbiological laboratory in the management of bacterial infections. (1966) (1)
A comparison of the efficacy of chloramphenicol (chloromycetin) and of penicillin in the treatment of pneumococcal lobar pneumonia. (1952) (0)
Symposium on antibiotics. Foreword. (1965) (0)
The relation of colonial morphology and antigenic structure to virulence in pneumococcus. (1952) (0)
A panel discussion. The prophylactic use of antibiotics. (1960) (0)
Credit for the discovery of pneumococcal capsular antigenicity. (1978) (0)
1I. NONIDENTIT¥ OF CELL WALL AND SOLUBLE CELL WALL-LIKE POLYSACCHARIDES DERIVED FRO~£ THE SAME AND FROM DIFFERENT PNEUMOCOCCAL STRAINS* BY GERALD SCHIFFMAN,:~ ProD., (2003) (0)
Pneumococcus Type LXXXII (Danish Type 48) (1965) (0)
The pneumonias. (1952) (0)
Letter: Pneumococcal vaccines. (1975) (0)
Acquisition of M P R O T E I N by Pneumococci T H R O U G H Transformation Reactions* (0)
Preventive Medicine in World War II, Medical Department, United States Army (2015) (0)
Clinicopathologic conference. (1956) (0)
Staphylococcal enteritis as a complication of antibiotic therapy. (1955) (0)
Diagnostic, Epidemiologic, Therapeutic and Prophylactic Considerations (2015) (0)
The prophylactic use of antibiotics. (1960) (0)
TYPE DISTRIBUTION OF KLYSIELLA PNEUMONIAE ISOLATED FROM THE HUMAN RESPIRATORY TRACT (2008) (0)
The pneumococcus and some men who came to Yale: the Dorothy M. Horstmann Lecture. (1993) (0)
Letter from Robert Austrian to Perry W. Wilson (1952) (0)
WFD meets CAP - Opportunities for the future (2006) (0)
i. The Treatment of Primary and Secondary Yaws with Penicillin. A Preliminary Report. (1944) (0)
Letter from Robert Austrian to Joshua Lederberg (1952) (0)
THANKS TO REVIEWERS1999 (1999) (0)
The Journal thanks the following consultants who, in addition to the members of the Editorial Board, gave their time to review manuscripts submitted in 1980. (1980) (0)
Pneumococcal pneumonia. Diagnostic, epidemiologic, therapeutic and prophylactic considerations. 1986. (2009) (0)
Concerning Friedlander, Gram and the etiology of labor pneumonia, an historical note. (1959) (0)
Lincomycin and Penicilling in the Treatment of Mild and Moderately Severe Pneumococcal Pneumonia1 (2015) (0)
Discussion of the Paper (1960) (0)
Queries and Minor Notes: Then and Now: PNEUMONIA (1984) (0)
Pneumococcal vaccine (2012) (0)

This paper list is powered by the following services:

Other Resources About Robert Austrian

en.wikipedia.org

What Schools Are Affiliated With Robert Austrian?

Robert Austrian is affiliated with the following schools:

Robert Austrian's Academic­Influence.com Rankings